All posts tagged "FDA approval"
-
226BiotechAtea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...
-
2.1KBiotechCytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
-
2.6KCannabisKaival Brands (OTCMKTS: KAVL) Could Do $1 Billion in Sales for 2021
Early projections were announced in early January that Kaival Brands (OTCMKTS: KAVL) could do $400-$450M in revenues for 2021, but we feel...
-
11.5KBiotechHandicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
-
4.8KBiotechThe Race for COVID-19 Tests Accelerating After FDA Loosens Rules
The manufacturing and distribution of COVID-19 test kits has been a major factor in the market decline costing the US stock market...
-
3.6KBiotechOur Readers Just Scored Big On AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
Back in August, we published this piece on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). At the time, the company had just collapsed subsequent...
-
1.9KBiotechALR Technologies Inc (OTCMKTS:ALRT) Gets A Boost From The FDA
Today, we will present a new profile, ALR Technologies Inc (OTCMKTS:ALRT), the medical device company, to which FDA has granted clearance for...
-
1.7KBiotechHere’s Something Markets Have Missed With BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
For a company that just picked up a major FDA approval, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is trading remarkably flat. Premarket on Thursday,...
